Skip to main content
. 2017 Nov 27;96(47):e8878. doi: 10.1097/MD.0000000000008878

Figure 5.

Figure 5

Comparing BP-DES with sirolimus-eluting stents (SES) during a follow-up period of 8 months to 3 years. Even if paclitaxel-eluting stents (PES) were excluded from the analysis, no significant difference was observed in the outcomes reported when comparing BP-DES with SES.